Type
1.
[Observation on the therapeutic effect of isobutylpiperazinyl rifamycin (R761) in treating lepromatous leprosy]. Chinese Journal of Dermatology [Internet]. 1983;16(4):223-7. Available from: http://manu16.magtech.com.cn/Jwk_cmazp/EN/abstract/abstract20834.shtml
Type
1.
Jian-Ping S, Wen-Zhong L. [Activity of Home-made Pefioxacin M.Leprae In Mice and Its Preliminary Effecto in the Treatment of Multibaciilary Leprosy]. Chinese Journal of Dermatology [Internet]. 1992;25(1):25-8. Available from: http://manu16.magtech.com.cn/Jwk_cmazp/EN/abstract/abstract23233.shtml
Type
1.
Lakshmi C, Srinivas CR. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports. International journal of dermatology. 2013;.
Type
1.
Malik R, Smits B, Reppas G, Laprie C, O’Brien C, Fyfe J. Ulcerated and nonulcerated nontuberculous cutaneous mycobacterial granulomas in cats and dogs. Veterinary dermatology. 2013;24(1):146-e33.
Type
1.
Gelber R, Grosses J. The chemotherapy of leprosy: An interpretive history. Leprosy review [Internet]. 2012;83(3):221–240. Available from: https://leprosyreview.org/article/83/3/00-221
Type
1.
Scollard D. Chemotherapy of leprosy has changed (almost) everything. Leprosy review [Internet]. 2012;83(3):245–246. Available from: https://leprosyreview.org/article/83/3/00-245
Type
1.
Alferink M, Werf T, Sopoh G, Agossadou D, Barogui Y, Assouto F, et al. Perceptions on the effectiveness of treatment and the timeline of Buruli Ulcer influence pre-hospital delay reported by healthy individuals. PLoS Negl Trop Dis [Internet]. 2013;7:e2014. Available from: http://dx.doi.org/10.1371%2Fjournal.pntd.0002014
Type
1.
Souza Cunha M, Virmond M, Schettini AP, Cruz. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Leprosy review [Internet]. 2012;83(3):261–268. Available from: https://leprosyreview.org/article/83/3/00-261
Type
1.
Deps, Guerra, Nasser, Simon. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy. Leprosy review [Internet]. 2012;83:305-7. Available from: https://leprosyreview.org/article/83/3/00-305
Type
1.
Dogra S, Kumaran, Narang, Radotra, Kumar. Clinical characteristics and outcome in multibacillary (MB) leprosy patients treated with 12 months WHO MDT-MBR: a retrospective analysis of 730 patients from a leprosy clinic at a tertiary care hospital of Northern India. Leprosy review [Internet]. 2013;84(1):65-7. Available from: https://leprosyreview.org/article/84/1/06-5075